{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:48:27Z","timestamp":1740134907059,"version":"3.37.3"},"reference-count":9,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,9]]},"DOI":"10.1182\/blood.2022018182","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T16:43:58Z","timestamp":1678380238000},"page":"1101-1102","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Harnessing ADR T cells to enhance allo-HCT"],"prefix":"10.1182","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2702-0381","authenticated-orcid":false,"given":"Melody","family":"Smith","sequence":"first","affiliation":[{"name":"1Stanford University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"10","key":"2023030916434929600_","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1182\/blood.2022016052","article-title":"Engineering T cells to suppress acute GVHD and leukemia relapse after allogeneic hematopoietic stem cell transplantation","volume":"141","author":"Mo","year":"2023","journal-title":"Blood"},{"issue":"12","key":"2023030916434929600_","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.3324\/haematol.2019.245688","article-title":"History of hematopoietic cell transplantation: challenges and progress","volume":"105","author":"Granot","year":"2020","journal-title":"Haematologica"},{"issue":"9","key":"2023030916434929600_","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/bmt.2017.22","article-title":"Ex\u00a0vivo T-cell depletion in allogeneic hematopoietic stem cell transplant: past, present and future","volume":"52","author":"Saad","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"2023030916434929600_","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1172\/JCI124218","article-title":"Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression","volume":"129","author":"Wachsmuth","year":"2019","journal-title":"J\u00a0Clin Invest"},{"issue":"2","key":"2023030916434929600_","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1046\/j.1365-2567.2003.01648.x","article-title":"Costimulation through OX40 is crucial for induction of an alloreactive human T-cell response","volume":"109","author":"Ukyo","year":"2003","journal-title":"Immunology"},{"issue":"5","key":"2023030916434929600_","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1097-0320(19991015)38:5<238::AID-CYTO6>3.0.CO;2-O","article-title":"Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease","volume":"38","author":"Lamb","year":"1999","journal-title":"Cytometry"},{"issue":"1","key":"2023030916434929600_","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41587-020-0601-5","article-title":"Engineered off-the-shelf therapeutic T cells resist host immune rejection","volume":"39","author":"Mo","year":"2021","journal-title":"Nat Biotechnol"},{"issue":"2","key":"2023030916434929600_","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nm.4258","article-title":"Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity","volume":"23","author":"Ghosh","year":"2017","journal-title":"Nat Med"},{"issue":"10","key":"2023030916434929600_","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood-2015-08-664250","article-title":"Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD","volume":"127","author":"Jacoby","year":"2016","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/141\/10\/1101\/2037334\/blood_bld-2022-018182-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/141\/10\/1101\/2037334\/blood_bld-2022-018182-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T23:11:18Z","timestamp":1679958678000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/141\/10\/1101\/494781\/Harnessing-ADR-T-cells-to-enhance-allo-HCT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,9]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,3,9]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2022018182","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2023,3,9]]}}}